Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Recent Patents on Anti-Cancer Drug Discovery
|
October 24, 2019
Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma Treatment
Romeo G Mihăilă
Recent Patents on Anti-Cancer Drug Discovery
|
May 4, 2022
Venetoclax in Acute Myeloid Leukemia
Romeo G Mihăilă
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|
June 29, 2016
Liver Graft versus Host Disease after Allogeneic Peripheral Stem Cell Transplantation: Update on Etiopathogenesis and Diagnosis
R-G Mihăilă
Recent Patents on Anti-Cancer Drug Discovery
|
September 28, 2020
Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology
Romeo G Mihăilă
Recent Patents on Anti-Cancer Drug Discovery
|
April 1, 2014
Could resveratrol be a useful drug for the treatment of malignant hemopathies?
Romeo G Mihăilă
Romanian Journal of Neurology and Psychiatry = Revue Roumaine De Neurologie Et Psychiatrie
|
April 1, 1995
Lumbosacral tumors with a retroperitoneal development
G Mihăilă, D Adam, T Roşca
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
March 26, 2019
Thrombin generation is increased in patients with <i>Clostridium difficile</i> colitis - a pilot study
Romeo G Mihăilă, Crina Cătană, Ariela L Olteanu, et al.
British Journal of Haematology
|
April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients
Adrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
American Journal of Hematology
|
October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients
Adrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Recent Patents on Anti-Cancer Drug Discovery
|
October 24, 2019
Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma Treatment
Romeo G Mihăilă
Recent Patents on Anti-Cancer Drug Discovery
|
May 4, 2022
Venetoclax in Acute Myeloid Leukemia
Romeo G Mihăilă
Romanian Journal of Internal Medicine = Revue Roumaine De Medecine Interne
|
June 29, 2016
Liver Graft versus Host Disease after Allogeneic Peripheral Stem Cell Transplantation: Update on Etiopathogenesis and Diagnosis
R-G Mihăilă
Recent Patents on Anti-Cancer Drug Discovery
|
September 28, 2020
Monoclonal Antibodies, Bispecific Antibodies and Antibody-Drug Conjugates in Oncohematology
Romeo G Mihăilă
Recent Patents on Anti-Cancer Drug Discovery
|
April 1, 2014
Could resveratrol be a useful drug for the treatment of malignant hemopathies?
Romeo G Mihăilă
Romanian Journal of Neurology and Psychiatry = Revue Roumaine De Neurologie Et Psychiatrie
|
April 1, 1995
Lumbosacral tumors with a retroperitoneal development
G Mihăilă, D Adam, T Roşca
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
|
March 26, 2019
Thrombin generation is increased in patients with <i>Clostridium difficile</i> colitis - a pilot study
Romeo G Mihăilă, Crina Cătană, Ariela L Olteanu, et al.
British Journal of Haematology
|
April 11, 2016
TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients
Adrian P Trifa, Claudia Bănescu, Mihaela Tevet, et al.
American Journal of Hematology
|
October 20, 2017
MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients
Adrian P Trifa, Claudia Bănescu, Anca S Bojan, et al.
Page
of 1